Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Stem cells may halt chronic kidney disease
Siamese cat
Researchers hope stem cell therapy may improve organ function in cats with advanced kidney disease.
US researchers launch new clinical trial for cats in advanced stages of disease

Stem cell therapy may be able to slow the progression of kidney disease in cats, US researchers say. A new clinical trial could even have wider implications for human medicine.

Previous studies at Colorado State University (CSU) found stem cells could stabilise the kidneys for cats with early stages of the disease.

A few of the cats with more advanced disease also appeared to benefit, however, showing limited disease progression years after receiving treatment. Encouraged by these results, the research team is now recruiting patients with stage four chronic kidney disease.

"We can't ignore the possibility that stem cells could help those cats too," said Jessica Quimby, leading the research.

Chronic kidney disease is common in older cats but the risk factors are poorly understood and other than a kidney transplant, there is no cure.

Stem cell therapy cannot reverse the kidney scarring that occurs in the later stages of the disease, but CSU researchers hope it may improve the overall function of the kidneys.

Shelley McCarron enrolled her six-year-old Siamese cat Baxter on a CSU study last year. She said: "I believe the treatments have stabilised his kidneys rather than restoring them, but we're grateful nonetheless. It's certainly better to be stabilised than continue to decline".

Patients in the trial will be given three stem cell injections, two weeks apart. Diagnostic tests will be carried out by veterinary surgeons before, during and after the treatment to determine the effect.

Dr Quimby said the research could one day benefit human health, as the disease progresses in a similar way in both humans and cats. "Kidney disease is indeed a huge and growing problem in human medicine. If we saw improvement with cats, we could relate it to curing humans".

Much of the trial costs are covered by Frankie's Fund for Feline Stem Cell Research. The fund was named after a seal point Siamese cat that helped CSU pioneer their stem cell research in 2009. A photo of Frankie is hung in Dr Quimby's office as a reminder of the hope offered by the treatment.

CSU researchers are seeking patients with stable, stage four chronic renal disease. Cats with other diseases will not be eligible. For more information, visit the clinical trial website.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.